Planning Treatment for Oesophago-gastric Cancer: a Maintenance Therapy Trial

Conditions

• Adenocarcinoma of the Oesophagus
• Adenocarcinoma of the Gastro-oesophageal Junction
• Adenocarcinoma of the Stomach

Interventions

• DRUG: Capecitabine
• DRUG: MEDI4736 (Durvalumab)
• DRUG: Trastuzumab
• DRUG: Rucaparib
• DRUG: Ramucirumab

Sponsor

Royal Marsden NHS Foundation Trust

Collaborators

• [object Object]
• [object Object]
• [object Object]
• [object Object]